Capecitabine Accord 500 mg film-coated tablets
2017-02-32-005
Phase 2 small_molecule active
Quick answer
Capecitabine Accord 500 mg film-coated tablets for Biliary tract cancer is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Biliary tract cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active